Table 1.
Vedolizumab Dose [mg/kg] | ||||
---|---|---|---|---|
Healthy Volunteers | UC Patients | |||
Parameter | 2.0 () | 10.0 () | 2.0 () | 10.0 () |
[μg/mL] | 58.4 | 243 | 60.4 | 291.9 |
AUC [μg·day/mL] | 955 | 4840 | 848 | 4373 |
14.1 | 14.8 | 15.1 | 20.6 | |
[L/day] | 0.164 | 0.139 | - | - |
[L] | 3.28 | 2.73 | - | - |
, maximum observed serum concentration; , area under the drug concentration–time curve (evaluated until the time of the last quantifiable concentration for healthy volunteers and between days 0 and 14 and days 85 and 99 for UC patients); , terminal estimation half-life; , total clearance; , volume of distribution during the terminal phase.